Compound Heterozygous DARS2 Mutations as a Mimic of Hereditary Spastic Paraplegia

Martje G. Pauly, Yorck Hellenbroich, Kathrin Grundmann-Hauser, Frauke Hinrichs, Katja Lohmann, Norbert Brüggemann*

*Corresponding author for this work
3 Citations (Scopus)
Original languageEnglish
JournalMovement Disorders Clinical Practice
Volume8
Issue number6
Pages (from-to)972-976
Number of pages5
DOIs
Publication statusPublished - 08.2021

Funding

The study was supported by the German Research Foundation (FOR2488), the German Research Foundation via the Clinician Scientist School Lübeck (DFG‐GEPRIS 413535489), and the Damp Foundation. The authors do not declare any conflicts of interest or competing interests. Martje G. Pauly is funded by the Clinician Scientist School Lübeck. Yorck Hellenbroich has nothing to report. Kathrin Grundmann‐Hauser has nothing to report. Frauke Hinrichs has nothing to report. Katja Lohmann received research funding from the German Research Foundation, the Damp‐Stiftung and the Movement Disorders Society and is member of the GP2 initiative within ASAP ( https://parkinsonsroadmap.org/gp2/ ). Norbert Brüggemann served as a consultant for Censa Pharmaceuticals, Centogene, and Bridgebio and is funded by the German Research Foundation (BR4328.2‐1, GRK1957).

Cite this